- Abstract:
-
BACKGROUND: Asthma is one of the commonest chronic diseases in the UK. Acute exacerbations of asthma are unpredictable, disruptive and frightening. They cause considerable morbidity and account for a large component of the health service costs of asthma. The widespread use of an asthma self-management plan, designed to encourage disease monitoring and timely intervention, can reduce exacerbations and is, therefore, recommended for all patients with asthma. Unfortunately, the majority of patie...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Publisher's version
- Grant:
- Health Technology Assessment Programme 10/143/01
- Publisher:
- BioMed Central Publisher's website
- Journal:
- Trials Journal website
- Volume:
- 17
- Issue:
- 1
- Pages:
- 499
- Publication date:
- 2016-10-13
- Acceptance date:
- 2016-09-16
- DOI:
- EISSN:
-
1745-6215
- Pubs id:
-
pubs:653362
- URN:
-
uri:8323b36f-d4a7-42dc-a26f-0ab37879703e
- UUID:
-
uuid:8323b36f-d4a7-42dc-a26f-0ab37879703e
- Local pid:
- pubs:653362
- Paper number:
- 1
- Language:
- English
- Keywords:
- Copyright holder:
- Skeggs et al.
- Copyright date:
- 2016
- Notes:
- © The Author(s) 2017. Open Access: This article is distributed under the terms of the Creative Commons Attribution 4.0 International License.
Journal article
FourFold Asthma Study (FAST): a study protocol for a randomised controlled trial evaluating the clinical cost-effectiveness of temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations.
Actions
Authors
Funding
+ National Institute for Health Research
More from this funder
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record